Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the Benefit of Finerenone

J Am Coll Cardiol. 2025 Jan 21;85(2):156-158. doi: 10.1016/j.jacc.2024.11.033. Epub 2024 Dec 10.

Authors

Amanda R Vest¹, Andrew J Sauer²

Affiliations

¹ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: [email protected].
² Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.

PMID: 39665698
DOI: 10.1016/j.jacc.2024.11.033

No abstract available

Keywords: body mass index; heart failure with preserved ejection fraction; mineralocorticoid receptor antagonist; obesity; waist-to-height ratio.

Publication types

Editorial